Nagane M - Search Results

1

Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.

Nitta Y, Shimizu S, Shishido-Hara Y, Suzuki K, Shiokawa Y, Nagane M. Nitta Y, et al. Among authors: nagane m. Cancer Med. 2016 Mar;5(3):486-99. doi: 10.1002/cam4.614. Epub 2016 Jan 18. Cancer Med. 2016. PMID: 26778701 Free PMC article.

2

Meningeal melanocytoma associated with ipsilateral nevus of Ota presenting as intracerebral hemorrhage: case report.

Hino K, Nagane M, Fujioka Y, Shiokawa Y. Hino K, et al. Among authors: nagane m. Neurosurgery. 2005 Jun;56(6):E1376; discussion E1376. doi: 10.1227/01.neu.0000159716.45457.bc. Neurosurgery. 2005. PMID: 15918956

3

Synergistic cytotoxicity through the activation of multiple apoptosis pathways in human glioma cells induced by combined treatment with ionizing radiation and tumor necrosis factor-related apoptosis-inducing ligand.

Nagane M, Cavenee WK, Shiokawa Y. Nagane M, et al. J Neurosurg. 2007 Mar;106(3):407-16. doi: 10.3171/jns.2007.106.3.407. J Neurosurg. 2007. PMID: 17367063

4

Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.

Nagane M, Kobayashi K, Ohnishi A, Shimizu S, Shiokawa Y. Nagane M, et al. Jpn J Clin Oncol. 2007 Dec;37(12):897-906. doi: 10.1093/jjco/hym132. Epub 2007 Dec 21. Jpn J Clin Oncol. 2007. PMID: 18156172

5

Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.

Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M. Kobayashi K, et al. Among authors: nagane m. Neurosurgery. 2008 Feb;62(2):493-503; discussion 503-4. doi: 10.1227/01.neu.0000316018.51292.19. Neurosurgery. 2008. PMID: 18382329

6

[Current topics of treatment for glioma and mechanism of drug resistance].

Nagane M. Nagane M. Gan To Kagaku Ryoho. 2008 Jun;35(6):918-25. Gan To Kagaku Ryoho. 2008. PMID: 18652052 Japanese. No abstract available.

7

Prolonged and severe thrombocytopenia with pancytopenia induced by radiation-combined temozolomide therapy in a patient with newly diagnosed glioblastoma--analysis of O6-methylguanine-DNA methyltransferase status.

Nagane M, Nozue K, Shimizu S, Waha A, Miyazaki H, Kurita H, Homori M, Fujioka Y, Shiokawa Y. Nagane M, et al. J Neurooncol. 2009 Apr;92(2):227-32. doi: 10.1007/s11060-008-9754-7. Epub 2008 Nov 27. J Neurooncol. 2009. PMID: 19037596

8

Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo.

Nagane M, Shimizu S, Mori E, Kataoka S, Shiokawa Y. Nagane M, et al. Neuro Oncol. 2010 Jul;12(7):687-700. doi: 10.1093/neuonc/nop069. Epub 2010 Feb 11. Neuro Oncol. 2010. PMID: 20511188 Free PMC article.

9

Serum pentosidine, an advanced glycation end product, indicates poor outcomes after acute ischemic stroke.

Ikeda T, Maruyama K, Ito N, Utagawa A, Nagane M, Shiokawa Y. Ikeda T, et al. Among authors: nagane m. J Stroke Cerebrovasc Dis. 2012 Jul;21(5):386-90. doi: 10.1016/j.jstrokecerebrovasdis.2010.10.004. Epub 2010 Nov 26. J Stroke Cerebrovasc Dis. 2012. PMID: 21111635

10

[Genetic alterations and biomarkers for glioma].

Nagane M. Nagane M. Brain Nerve. 2012 May;64(5):537-48. Brain Nerve. 2012. PMID: 22570067 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters